ProCE Banner Activity

CE / CME

Advancing Care for Pediatric Atopic Dermatitis: What APPs Need to Know About Current and Emerging Systemic Therapies

Clinical Thought

Explore practical strategies for APPs to integrate current and emerging systemic therapies into the management of moderate to severe pediatric atopic dermatitis. This commentary emphasizes patient-centered approaches, effective communication with caregivers, and optimizing treatment outcomes through evidence-based care.

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: November 21, 2024

Expiration: November 20, 2025

Share

Faculty

Katie Smiley

Katie Smiley, PA-C, MSHS

Grants and Clinical Director
Clinical Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children's Hospital, Allergy & Asthma Medical Group and Research Center
San Diego, California

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and National Eczema Association

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Target Audience

This education is intended for pediatric dermatologists, dermatologists, pediatricians, allergist/immunologists, and nurse practitioners and physician associates who manage children with moderate to severe atopic dermatitis.

Program Learning Goal

The goal of this educational activity is to improve learners’ knowledge and competence regarding the management of children with moderate to severe atopic dermatitis.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Integrate patient-reported and caregiver-reported outcomes into diagnosis, disease severity assessment, and treatment advancement decisions for children with moderate to severe AD

  • Recognize pediatric candidates for available and emerging systemic therapies for moderate to severe AD

  • Collaborate with patients and caregivers to incorporate personal history, preferences, disease triggers, and goals into management plans

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Katie Smiley, PA-C, MSHS

Grants and Clinical Director
Clinical Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children's Hospital, Allergy & Asthma Medical Group and Research Center
San Diego, California

Katie Smiley, PA-C, MSHS: consultant/advisor/speaker: Novartis.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, and the National Eczema Association do not have any relevant financial relationships to disclose, except Wendy Smith Begolka and Joy Wan, MD, MSCE, as noted below:

Wendy Smith Begolka: consultant/advisor/speaker: Amgen, Pfizer, Sanofi; researcher: Pfizer

Joy Wan, MD, MSCEconsultant/advisor/speaker: Astria Therapeutics, Sun Pharmaceuticals.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 21, 2024, through November 20, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the National Eczema Association. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

Physician Associate Continuing Medical Education

AAPA CME Accreditation - AAPA

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until November 20, 2025. PAs should only claim credit commensurate with the extent of their participation.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.